Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stephan

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Haematologica|July 25, 2024
A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilitiesJacob J Junco, Max Rochette, Michelle Alozie, et al.
Revista De Neurologia|May 12, 2021
Brain activity in well-controlled perinatally HIV-infected young adults: a fMRI pilot studyM Martín Bejarano-García, B Ruiz-Sáez, B Zamora, et al.
HIV Medicine|October 13, 2020
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitorsG Schuettfort, L Boekenkamp, A Cabello, et al.
Cancer Research|December 9, 2024
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell TumorsThomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, et al.
Gynecologic Oncology|August 31, 2025
Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor modelsAllison L Brodsky, Thomas Welte, Veena K Vuttaradhi, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancerRongjie Fu, Yalong Wang, Ishita Rehman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Cancer Research Communications|May 21, 2026
Drug screening of sarcoma cells: finding shared sensitivitiesHannah C Beird, Carl Ho, Roberto Cardenas-Zuniga, et al.
Molecular Cancer Therapeutics|January 16, 2026
Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer CellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Haematologica|July 25, 2024
A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilitiesJacob J Junco, Max Rochette, Michelle Alozie, et al.
Revista De Neurologia|May 12, 2021
Brain activity in well-controlled perinatally HIV-infected young adults: a fMRI pilot studyM Martín Bejarano-García, B Ruiz-Sáez, B Zamora, et al.
HIV Medicine|October 13, 2020
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitorsG Schuettfort, L Boekenkamp, A Cabello, et al.
Cancer Research|December 9, 2024
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell TumorsThomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, et al.
Gynecologic Oncology|August 31, 2025
Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor modelsAllison L Brodsky, Thomas Welte, Veena K Vuttaradhi, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancerRongjie Fu, Yalong Wang, Ishita Rehman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Cancer Research Communications|May 21, 2026
Drug screening of sarcoma cells: finding shared sensitivitiesHannah C Beird, Carl Ho, Roberto Cardenas-Zuniga, et al.
Molecular Cancer Therapeutics|January 16, 2026
Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer CellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Pageof 18